iTeos Therapeutics, Inc.: cashflow_financing
| Value | {"amount": 22474000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-06-30 |
| Status | current |
| Entity | iTeos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:13:01.793164+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/01286af4-b625-49e1-96f2-5a68c4df3777
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-042219Retrieved: 2026-08-19T18:13:01.793164+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001808865/cashflow-financing/2019-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/01286af4-b625-49e1-96f2-5a68c4df3777
History
- no predecessors — first report